C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
Project Number5R01CA057341-06
Contact PI/Project LeaderDANG, CHI V.
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
DESCRIPTION: During the last funding period, the applicant has made a
number of published as well as preliminary observations that suggest: 1)
c-Myc mediated anchorage independent growth of rat fibroblast is associated
with the deregulated expression of genes including cyclin A, ornithine
decarboxylase and several genes that he has cloned and are as yet undefined,
2) Deregulated cyclin A expression induces anchorage independent growth and
apoptosis of rat fibroblasts, 3) Chromosomal localization of the MXI-1 gene
and loss of heterozygosity studies suggest that MXI-1 is a tumor suppressor
gene in human prostate cancer and glioblastomas, and 4) TNFb (lymphotoxin)
selectively induces apoptosis in Myc- overexpressing fibroblasts. A unique,
rapid and efficient model and systematic approach to identify c-Myc
responsive genes has been established. Based on these observations and to
reach the long term goal of delineating the mechanisms by which c-Myc
transform cells, experiments are proposed to answer the following questions:
1) What are the genes that are upregulated by c-Myc, and how do they
contribute to neoplasia? 2) What are the genes that are downregulated by
c-Myc and how do they participate in neoplasia? 3) What are the effects of
Mxi-1 on the expression of c-Myc target genes? and 4) Which c-Myc target
genes predispose fibroblasts to lymphotoxin-mediated apoptosis, and is this
pathway exploitable for therapeutic purposes?
No Sub Projects information available for 5R01CA057341-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA057341-06
Patents
No Patents information available for 5R01CA057341-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA057341-06
Clinical Studies
No Clinical Studies information available for 5R01CA057341-06
News and More
Related News Releases
No news release information available for 5R01CA057341-06
History
No Historical information available for 5R01CA057341-06
Similar Projects
No Similar Projects information available for 5R01CA057341-06